Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Nitrogen heterocycle
Patent
1992-08-24
1994-12-13
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Nitrogen heterocycle
424 7837, A61K 3174, C07D20700
Patent
active
053728076
ABSTRACT:
The present invention concerns a method for treating fibrotic conditions by administration of an effective amount of an antifibrotic agent. The antifibrotic agent is preferably a proline analog, such as cis-4-hydroxy-L-proline (cHyp). The antifibrotic agent is operatively linked to a monomer or a polymer, with or without a linking compound, e.g., lysine. Intravenous administration is preferred. The present method facilitates the delivery and release of the antifibrotic agent to inhibit collagen accumulation and thereby to treat fibrosis where collegen metabolism is implicated. A reduced quantity of the antifibrotic agent and a corresponding reduction in the potential for toxicity resulting from prolonged administration thereof may be realized.
REFERENCES:
Am. Rev. Resp. Dis 139:A172 (Abstract) 1989.
Am. Rev. Resp. Dis. 141:A186 (Abstract) 1990.
Lubec G. et al. Amino Acids:Chemistry, Biology and Medicine pp. 634-642 (1990).
Gean Keria F.
Kahn Joachim
Liao Wei-Chi
Poiani George J.
Riley David J.
Kulkosky Peter F.
Page Thurman K.
Rutgers University
University of Medicine and Dentistry of New Jersey
LandOfFree
Polymers containing antifibrotic agents, compositions containing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymers containing antifibrotic agents, compositions containing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymers containing antifibrotic agents, compositions containing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1191772